Litcius/Paper detail

Immunodeficiency associated with a novel functionally defective variant of SLC19A1 benefits from folinic acid treatment

Veysel Gök, Şerife Erdem, Yeşim Haliloğlu, Atıl Bişgin, Serkan Belkaya, Kemal Erdem Başaran, Mehmed Fatih Canatan, Alper Özcan, Ebru Yılmaz, Can Acıpayam, Musa Karakükçü, Halit Canatan, Hüseyin Per, Türkan Patıroğlu, Ahmet Eken, Ekrem Ünal

2022Genes and Immunity15 citationsDOI

Topics & Concepts

BiologyFolinic acidGeneticsChemotherapyFluorouracilFolate and B Vitamins ResearchImmunodeficiency and Autoimmune DisordersRNA modifications and cancer
Immunodeficiency associated with a novel functionally defective variant of SLC19A1 benefits from folinic acid treatment | Litcius